YTHDC1 Knockout Cell Line (A549)

The choice depends on the experimental question, and YTHDC1's multifunctional nature makes this distinction particularly important. The Knockout line is appropriate for asking whether YTHDC1 is required for pre-mRNA splicing, nuclear export of m6A transcripts, p53 response, or ferroptosis sensitivity — all functions characterized in A-549. Overexpression is useful for testing sufficiency hypotheses or for studying YTHDC1 condensate formation, which is concentration-dependent. For most YTHDC1 research questions in lung cancer biology, the EDITGENE Knockout line is the more informative tool — particularly because published YTHDC1 functional data in A-549 (p53 reporter screens, ferroptosis assays, FSP1 splicing) was generated in the loss-of-function context. Rescue with wild-type or m6A-binding-defective YTHDC1 is essential for assigning observed phenotypes to m6A reader activity versus m6A-independent functions, which have been reported for p53 regulation.

Primary applications: • Splicing analysis: RNA-seq or rMATS analysis to identify alternative splicing events — particularly exon inclusion changes — associated with YTHDC1 loss; PAR-CLIP or eCLIP can map direct binding sites. • p53 pathway studies: p21 reporter assays and p53 target gene expression profiling to assess YTHDC1's role in modulating the DNA damage-p53 transcriptional axis in A-549. • Ferroptosis assays: RSL3 or Erastin sensitivity assays combined with FSP1 isoform analysis to probe YTHDC1's role in alternative polyadenylation-mediated ferroptosis resistance. • Nuclear export studies: fractionation and export kinetics assays for m6A-modified transcripts. • MeRIP-seq + RNA-seq: transcriptome-wide identification of m6A-regulated transcript classes affected by YTHDC1 loss. EDITGENE recommends this model for researchers investigating nuclear m6A biology, RNA splicing regulation, p53 pathway control, and lung cancer epitranscriptomics.

Yes, and rescue experiments are particularly important for YTHDC1 because it has both m6A-dependent and m6A-independent functions: • Construct design: use a codon-modified YTHDC1 sequence with a C-terminal tag. YTHDC1 is exclusively nuclear — confirm correct nuclear localization of exogenous protein before functional assays. Nuclear export sequence-disrupting mutations should be avoided. • m6A-binding-defective rescue: the W377A mutation in the YTH domain abolishes m6A binding. This is the critical control for distinguishing m6A-dependent functions (splicing, nuclear export) from m6A-independent functions (such as transcriptional regulation of TP53 reported in A-549). • Phenotype-specific rescue interpretation: for p53 pathway phenotypes, both wild-type and W377A rescue may be required to distinguish m6A-dependent from m6A-independent mechanisms. For splicing or nuclear export phenotypes, only wild-type should rescue. • Condensate considerations: YTHDC1 forms nuclear condensates in a concentration-dependent manner. Rescue at supraphysiological levels can produce aberrant condensate behavior — titrate to endogenous levels using inducible systems where possible. A-549 supports efficient lentiviral transduction and stable integration, with established protocols for YTHDC1 rescue published in the lung cancer epitranscriptomics literature.